Toth Financial Advisory
KNSA icon

Toth Financial Advisory’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Toth Financial Advisory’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.55M Buy
20,825
+100
+0.5% +$7.36K 0.16% 112
2026
Q2 		$1.33M Hold
20,725
– – 0.13% 128
2026
Q1 		$998K Sell
20,725
-840
-4% -$37.2K 0.11% 131
2025
Q4 		$890K Hold
21,565
– – 0.1% 143
2025
Q3 		$837K Buy
21,565
+10,865
+102% +$353K 0.09% 144
2025
Q2 		$296K Buy
+10,700
New +$272K 0.03% 194

Other funds holding KNSA

Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Linden Thomas Advisory Services
Linden Thomas Advisory Services Charlotte, North Carolina $1.26B AUM 37.95% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Sowell Financial Services
Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return
TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Sigma Planning Corp
Sigma Planning Corp Ann Arbor, Michigan $3.88B AUM 23.38% 1-Year Est. Return
Juncture Wealth Strategies
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

Toth Financial Advisory's KNSA Position: Q3 2026 in Review

Toth Financial Advisory increased its Kiniksa Pharmaceuticals (KNSA) stake by 0.48% in Q3 2026, buying an estimated $7.36K and bringing the position to 20,825 shares worth $1.55M. The position accounts for 0.16% of the portfolio, ranked #112.

Toth Financial Advisory first reported a position in KNSA in Q2 2025 and has held it in 6 quarters since. 40 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • Toth Financial Advisory held 20,825 shares of Kiniksa Pharmaceuticals worth $1.55M as of Q3 2026.
  • Toth Financial Advisory bought 100 Kiniksa Pharmaceuticals shares in Q3 2026, an estimated $7.36K.
  • Kiniksa Pharmaceuticals made up 0.16% of Toth Financial Advisory's portfolio in Q3 2026, its #112 holding.
  • Toth Financial Advisory first reported a position in Kiniksa Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • 40 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.